[Deep candidiasis in agranulocytic patients: mycological and serological surveillance in 91 febrile episodes and management of an antifungal and antibacterial protocol].
This study took place between February 1984 and February 1985 in 76 febrile neutropenic patients. We evaluated the whole mycological and serological results, in 91 febrile episodes. We separated two groups: group I (acute leukemia, chronic myeloïd leukemia, medullar aplasia, lymphomas) and group II (chronic lymphoïd leukemia, Hodgkin disease, myelomas, solid tumors). Patients were included in this study if they developed a temperature of 38.5 degrees C or greater and if they had less than five hundred neutrophils per mm3. They were treated with mono or bi-antibiotherapy. If the patient remained febrile more than 72 hours, an antifungal therapy was added (Amphotericin B IV). Through these weekly results, we conclude: the high frequency of digestive tract candidiasis in such patients; disseminated candidiasis occurs only in the first group patients with fungal digestive colonization; the overall response rate in this study was 77 per cent. This underlines the interest of empiric treatment with amphotericin B IV.
Lebeau
B
B
Service de Parasitologie, CHU de Grenoble.
Grillot
R
R
Michallet
M
M
Goullier-Fleuret
A
A
Corront
B
B
Bru
J P
JP
D000380:Agranulocytosis / Q000150:complications* / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D005260:Female; D005334:Fever / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D008297:Male; D018805:Sepsis / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents
Candidoses profondes chez l'agranulocytaire: surveillance mycologique et sérologique au cours de 91 épisodes fébriles et gestion d'un protocole antibactérien et antifongique.